- About Us
- Advertise
- Contact Us
- Editorial Staff
- Privacy Policy
- Terms & Conditions
- Do Not Sell My Information
© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
Yale Cancer Center | Strategic Alliance Partners
%20(2).jpg?fit=crop&auto=format)
Latest from Yale Cancer Center
Tebentafusp-tebn Use in HLA-A*02:01–Positive Unresectable or Metastatic Uveal Melanoma
October 18, 2022
Article
The agent is representative of a new class of drug, ImmTAC.
With Oral Agents Common, Oncology Pharmacists Are Essential in Treatment of Multiple Myeloma
November 15, 2021
Video
With so many approved regimens and common use of oral agents in the treatment of multiple myeloma, oncology pharmacists are essential team members.
Tackling Disparities in Oncology Requires Action, As Well As Research
September 23, 2021
Video
Andrea Silber, MD, said the COVID-19 pandemic has exacerbated disparities that already existed within oncology care, and she said the effects of these disparities on patients are very real and direct.
Pharmacy Times® Expands Its Strategic Alliance Partnership Program With the Addition of Yale Cancer Center
January 27, 2021
Article
Pharmacy Times®, the leading multimedia resource for pharmacy professionals, is excited to announce Yale Cancer Center is now part of its Strategic Alliance Partnership program.